|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01952 EVEREST MED-B
Nominal 
38.750 -0.750 (-1.899%) | 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | |
| Turnover | 125,932 | 884.459% | 12,792 | 54 | 0 | 0 |
| Cost of Sales | (34,414) | 640.883% | (4,645) | (23) | -- | -- |
| Gross Profit | 91,518 | 1023.334% | 8,147 | 31 | -- | -- |
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | 3,667 | -- | (23,362) | (6,452) | (4,937,983) | (36,453) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | (844,463) | 241.508% | (247,275) | (1,008,719) | (5,658,165) | (214,512) | |
| Taxation | 0 | -- | (8) | 0 | 0 | 0 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 0 | -- | 0 | 0 | 0 | 0 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (844,463) | 241.497% | (247,283) | (1,008,719) | (5,658,165) | (214,512) | |
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | |
| Net Finance Costs / (Income) | (84,608) | 157.269% | (32,887) | (24,065) | 31,725 | 1,947 |
| Depreciation & Amortisation | 76,776 | 79.501% | 42,772 | 31,124 | 20,395 | 10,004 |
| Directors' Emoluments | 42,349 | -38.382% | 68,728 | 106,387 | 85,547 | 15,504 |
| 2023/12 - Final | %Chg (Compare to Final) | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2023/12 - Final | %Chg (Compare to Final) | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| EPS (cts) | -270.000 | 225.301% | -83.000 | -344.000 | -6,629.000 | -4,104.000 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | -- |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | (2.457) | -- | (3.883) | (2.489) | (5.529) | -- |
| NBV per share ($) | 15.349 | -- | 18.118 | 19.737 | 23.331 | -- |
| Remarks: | Real time quote last updated: 21/11/2024 18:00 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB -632,413,000 |
| %Change | 49.291% |
| EPS / (LPS) | RMB -1.970 |
| NBV Per Share (¥) | RMB 13.567 |